ReviewTheranostics2021
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
Roberta Mastrantonio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this papercites it
ReviewTheranostics2021
Roberta Mastrantonio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.